公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
---|---|---|---|---|---|---|
2020 | Landscape of mitochondria genome and clinical outcomes in stage 1 lung adenocarcinoma | Raghav L.; Chang Y.-H.; Hsu Y.-C.; Li Y.-C.; Chen C.-Y.; Yang T.-Y.; Chen K.-C.; Hsu K.-H.; Tseng J.-S.; Chuang C.-Y.; Lee M.-H.; Wang C.-L.; HUEI-WEN CHEN ; SUNG-LIANG YU ; SHENG-FANG SU ; Yuan S.-S.; Chen J.J.W.; Ho S.-Y.; Li K.-C.; PAN-CHYR YANG ; Chang G.-C.; Chen H.-Y. | Cancers | 8 | 8 | |
2021 | The M1/M2 spectrum and plasticity of malignant pleural effusion-macrophage in advanced lung cancer | Wu M.-F.; Lin C.-A.; Yuan T.-H.; Yeh H.-Y.; SHENG-FANG SU ; Guo C.-L.; Chang G.-C.; Li K.-C.; CHAO-CHI HO ; HUEI-WEN CHEN | Cancer Immunology, Immunotherapy | 23 | 23 | |
2008 | MicroRNA Signature Predicts Survival and Relapse in Lung Cancer | SUNG-LIANG YU ; HSUAN-YU CHEN; Chang G.-C.; Chen C.-Y.; HUEI-WEN CHEN ; Singh S.; Cheng C.-L.; CHONG-JEN YU ; Lee Y.-C.; Chen H.-S.; Su T.-J.; Chiang C.-C.; Li H.-N.; Hong Q.-S.; Su H.-Y.; Chen C.-C.; Chen, W.-J.; Liu C.-C.; Chan W.-K.; WEI J. CHEN ; Li K.-C.; Chen J.J.W.; PAN-CHYR YANG | Cancer Cell | 725 | 672 | |
2009 | p53 controls cancer cell invasion by inducing the MDM2-mediated degradation of Slug | Wang S.-P.; Wang W.-L.; YIH-LEONG CHANG ; CHEN-TU WU ; Chao Y.-C.; Kao S.-H.; ANG YUAN ; CHUNG-WU LIN ; Yang S.-C.; Chan W.-K.; Li K.-C.; Hong T.-M.; PAN-CHYR YANG | Nature Cell Biology | 402 | 395 | |
2012 | Pretreatment Epidermal Growth Factor Receptor (EGFR) T790M mutation predicts shorter EGFR tyrosine kinase inhibitor response duration in patients with non-small-cell lung cancer | KANG-YI SU ; Chen H.-Y.; Li K.-C.; Kuo M.-L.; CHIH-HSIN YANG ; Chan W.-K.; Ho B.-C.; Chang G.-C.; JIN-YUAN SHIH ; SUNG-LIANG YU ; PAN-CHYR YANG | Journal of Clinical Oncology | 462 | 428 | |
2015 | R331W missense mutation of oncogene YAP1 is a germline risk allele for lung adenocarcinoma with medical actionability | Chen H.-Y.; SUNG-LIANG YU ; Ho B.-C.; KANG-YI SU ; Hsu Y.-C.; Chang C.-S.; Li Y.-C.; Yang S.-Y.; Hsu P.-Y.; Ho H.; Chang Y.-H.; Chen C.-Y.; Yang H.-I.; Hsu C.-P.; Yang T.-Y.; Chen K.-C.; Hsu K.-H.; Tseng J.-S.; Hsia J.-Y.; Chuang C.-Y.; Yuan S.; Lee M.-H.; Liu C.-H.; Wu G.-I.; Hsiung C.A.; Chen Y.-M.; Wang C.-L.; Huang M.-S.; CHONG-JEN YU ; KUAN-YU CHEN ; Tsai Y.-H.; Su W.-C.; HUEI-WEN CHEN ; Chen J.J.W.; Chen C.-J.; Chang G.-C.; PAN-CHYR YANG ; Li K.-C. | Journal of Clinical Oncology | 76 | 71 | |
2012 | The role of IL-8 in the SDF-1α/CXCR4-induced angiogenesis of laryngeal and hypopharyngeal squamous cell carcinoma | Li K.-C.; Huang Y.-H.; Ho C.-Y.; CHIA-YU CHU ; Cha S.-T.; Tsai H.-H.; JENG-YUH KO ; Chang C.-C.; CHING-TING TAN | Oral Oncology | 21 | 21 | |
2015 | Slug is temporally regulated by cyclin e in cell cycle and controls genome stability | Wang W.-L.; Huang H.-C.; Kao S.-H.; Hsu Y.-C.; Wang Y.-T.; Li K.-C.; Chen Y.-J.; SUNG-LIANG YU ; Wang S.-P.; Hsiao T.-H.; PAN-CHYR YANG ; HSIAO-CHUN HUANG | Oncogene | 30 | 30 | |
2021 | Tumor microenvironment-based screening repurposes drugs targeting cancer stem cells and cancer-associated fibroblasts | Lee P.-J.; CHAO-CHI HO ; Ho H.; Chen W.-J.; Lin C.-H.; Lai Y.-H.; Juan Y.-C.; Chu W.-C.; Lee J.-H.; SHENG-FANG SU ; Chen H.-Y.; Chen J.J.W.; Chang G.-C.; Li K.-C.; PAN-CHYR YANG ; HUEI-WEN CHEN | Theranostics | 10 | 10 | |
2019 | Tumor mutation burden and recurrent tumors in hereditary lung cancer | Hsu Y.-C.; Chang Y.-H.; Chang G.-C.; Ho B.-C.; Yuan S.-S.; Li Y.-C.; Zeng J.-W.; SUNG-LIANG YU ; Li K.-C.; PAN-CHYR YANG ; Chen H.-Y. | Cancer Medicine | 13 | 13 | |
2013 | α-catulin drives metastasis by activating ILK and driving an αvβ3 integrin signaling axis | Liang C.-H.; Chiu S.-Y.; Hsu I.-L.; Wu Y.-Y.; Tsai Y.-T.; Ke J.-Y.; SZU-HUA PAN ; Hsu Y.-C.; Li K.-C.; PAN-CHYR YANG ; Chen Y.-L.; Hong T.-M. | Cancer Research | 29 | 28 |